Minapharm Pharmaceuticals (CAI:MIPH) Scaled Net Operating Assets : 0.79 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Minapharm Pharmaceuticals's operating assets for the quarter that ended in Dec. 2023 was E£6,786 Mil. Minapharm Pharmaceuticals's operating liabilities for the quarter that ended in Dec. 2023 was E£1,408 Mil. Minapharm Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2022 was E£6,806 Mil. Therefore, Minapharm Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.79.

Minapharm Pharmaceuticals Scaled Net Operating Assets Historical Data

The historical data trend for Minapharm Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals Scaled Net Operating Assets Chart

Minapharm Pharmaceuticals Annual Data

Trend

Dec22

Dec23

Scaled Net Operating Assets

0.55

0.79

Minapharm Pharmaceuticals Semi-Annual Data
	Dec22	Dec23
Scaled Net Operating Assets	0.55	0.79

Competitive Comparison of Minapharm Pharmaceuticals's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Minapharm Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Minapharm Pharmaceuticals's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Minapharm Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Minapharm Pharmaceuticals's Scaled Net Operating Assets falls into.

Minapharm Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Minapharm Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(6785.724	-	1407.622)	/	6805.891
=	0.79

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	8703.565	-	1917.841
=	6785.724

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	5186.248	-	1489.102	-	2289.524
=	1407.622

Minapharm Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2023 )
=	(Operating Assets (Q: Dec. 2023 )	-	Operating Liabilities (Q: Dec. 2023 ))	/	Total Assets (Q: Dec. 2022 )
=	(6785.724	-	1407.622)	/	6805.891
=	0.79

where

	Operating Assets		(Q: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	8703.565	-	1917.841
=	6785.724

	Operating Liabilities		(Q: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	5186.248	-	1489.102	-	2289.524
=	1407.622

Minapharm Pharmaceuticals Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Minapharm Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY

Website

https://www.minapharm.com

Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines